ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,555Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 47

$643K Total Retail Price of All Prescriptions

Rank: 9 out of 47

598 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,199 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 435 385 1 4
LISINOPRIL 373 345 2 2
AMLODIPINE BESYLATE 370 326 3 3
METOPROLOL TARTRATE 329 291 4 6
WARFARIN SODIUM 269 263 5 13
FUROSEMIDE 260 252 6 7
OMEPRAZOLE 210 180 7 5
SIMVASTATIN 198 187 8 1
HYDROCODONE-ACETAMINOPHEN 197 177 S3 9 9
METFORMIN HCL 177 162 10 8
HYDROCHLOROTHIAZIDE 174 168 11 10
FENTANYL 164 158 S2 12 88
AZITHROMYCIN 164 139 12 47
PANTOPRAZOLE SODIUM 163 138 14 34
POTASSIUM CHLORIDE 159 145 15 22
ATENOLOL 144 125 16 12
PRANDIN 122 102 17 75
ATORVASTATIN CALCIUM 121 105 18 11
PRAVASTATIN SODIUM 116 111 19 14
AMOXICILLIN 103 84 20 110
SUCRALFATE 99 91 21 159
ISOSORBIDE MONONITRATE ER 98 97 22 25
METOPROLOL SUCCINATE 95 95 23 20
FAMOTIDINE 93 91 24 46
SERTRALINE HCL 91 80 25 28
NEXIUM 89 72 26 19
RAMIPRIL 88 74 27 132
CLOPIDOGREL 87 85 28 29
KLOR-CON M20 87 81 28 69
METHYLPREDNISOLONE 86 64 30 119
TRAMADOL HCL 85 63 31 18
NAPROXEN 83 68 32 72
TAMSULOSIN HCL 78 73 33 30
PREDNISONE 74 71 34 71
NAMENDA 73 73 35 44
DIOVAN 70 56 36 23
VENLAFAXINE HCL ER 66 49 37 146
OXYCODONE-ACETAMINOPHEN 64 60 S2 38 66
RANITIDINE HCL 61 57 39 26
GABAPENTIN 59 42 40 15
ZOLPIDEM TARTRATE 59 53 40 16
CITALOPRAM HBR 59 48 40 24
CELEBREX 58 54 43 101
LANTUS 58 39 43 60
CLONIDINE HCL 58 41 43 67
CIPROFLOXACIN HCL 58 46 43 90
MECLIZINE HCL 57 56 47 41
PAROXETINE HCL 57 48 47 63
CYMBALTA 55 38 49 96
CYCLOBENZAPRINE HCL 53 29 R 50 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 47 51 21
PLAVIX 52 51 51 49
GLIPIZIDE 52 45 51 78
BYSTOLIC 50 48 54 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.